Dr. S. Stanley Young is currently the CEO of CGStat and previously worked at Eli Lilly, GlaxoSmithKline, and the National Institute of Statistical Sciences on questions of applied statistics. His current interest is studying methods used in the evaluation of observational studies. He also works on bioinformatics problems.

Dr. Young graduated from North Carolina State University with a BS, MES, and a PhD in Statistics and Genetics. He worked in the pharmaceutical industry on all phases of pre-clinical research. He has authored or co-authored over 70 papers including six “best paper” awards, and a highly cited book, Resampling-Based Multiple Testing. He has three issued patents. He is interested in all aspects of applied statistics. He conducts research in data mining.

Dr. Young is a Fellow of the American Statistical Association and the American Association for the Advancement of Science. He is an adjunct professor of statistics at North Carolina State University, the University of Waterloo, and the University of British Columbia where he has co-directed thesis work. He is also an adjunct professor of biostatistics at the Jiann-Ping Hsu College of Public Health at Georgia Southern University. Dr. Young served on the Scientific Advisory Board of the U.S. Environmental Protection Agency, 2017-2021.